Bussaglia, E.
Pratcorona, M.
Carricondo, M.
Sansegundo, L.
Rubio, M. A.
Monter, A.
Brell, A.
Badell, I.
Esteve, J.
Arnan, M.
Talarn, C.
Tormo, M.
García, A.
Vall-Llovera, F.
Ortin, X.
Pedro, C.
Bargay, J.
Brunet, S.
Sierra, J.
Nomdedéu, J.
Funding for this research was provided by:
Instituto de Salud Carlos III (13/2729;16/094)
Fundación Mutua Madrileña (08/FMMA)
Agència de Gestió d’Ajuts Universitaris i de Recerca (PERIS SLT 002/16/0043, 2014-SGR-383;2017-SGR-1395)
Article History
Received: 24 October 2019
Accepted: 13 January 2020
First Online: 15 February 2020
Compliance with ethical standards
:
: Josep Nomdedeu (JN) received honoraria from Novartis. The rest of the authors (EB, MP, MC, LS, MAR, AM, AB, IB, JE, MA, CT, MT, AG, FV, XO, CP, JB, SB, and JS) had nothing to disclose.
: All procedures were following the ethical standards of the Hospital de Sant Pau research committee, followed the SEHH recommendations, and were in accordance with the 1964 Helsinki declaration and its later amendments.
: Informed consent was obtained from all individual participants included in the study.